Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Heavy Menstrual Bleeding: later-stage trial registry
3 of 10 indexed Heavy Menstrual Bleeding trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 3 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Heavy Menstrual Bleeding: 10 US clinical trials tracked, 3 recruiting.
Heavy Menstrual Bleeding is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is MicroCube, running 1 of these trials.
Enrollment posture brief
Registry condition heavy-menstrual-bleeding
OPEN 3 | RECR 30% | LATE 4 | EARLY 0 | RANK #1724 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)
Heavy Menstrual Bleeding lists 3 open slots (30% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Heavy Menstrual Bleeding on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Heavy Menstrual Bleeding is recruiting below its size-band peers.
3 of 10 indexed trials (30%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Heavy Menstrual Bleeding trials is spread across many organizations.
MicroCube accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Heavy Menstrual Bleeding enrolment sits around 219 participants.
Median target enrolment is 219 among the 10 trials that report a genuine target (sentinel values excluded). 4 of those (40%) plan for fewer than 100 participants.
-
Heavy Menstrual Bleeding research is mostly interventional.
8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Oregon Health and Science University
NCT05916469
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
Channel Medsystems
NCT05922657
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Rejoni
NCT06634719
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
ObsEva
NCT03070899
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences
NCT03103087
Minitouch Endometrial Ablation System Treatment for Menorrhagia: An Evaluation of Safety & Effectiveness
MicroCube
NCT04267562
Efficacy and Safety Study of XP12B in Women With Menorrhagia
Ferring Pharmaceuticals
NCT00386308
Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial
Spark Biomedical
NCT06814028
Tranexamic Acid in Adolescents With Heavy Menstrual Bleeding
Nationwide Children's Hospital
NCT01846507
Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease
Five Liters
NCT06064851
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Heavy Menstrual Bleeding records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Heavy Menstrual Bleeding trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Heavy Menstrual Bleeding page
10 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Heavy Menstrual Bleeding trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- MicroCube sponsors the most Heavy Menstrual Bleeding trials on record, review their full trial history before evaluating a specific study. See MicroCube's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Heavy Menstrual Bleeding condition card totals 10 registered trials; most-linked intervention Volta System; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.